-
-
7 . Periodical
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- 저자
- by Monk, Phillip D; Marsden, Richard J; Tear, Victoria J; Brookes, Jody; Batten, Toby N, et al.
- 소스
- The Lancet Respiratory Medicine; February 2021, Vol. 9 Issue: 2 p196-206, 11p